Previous 10 | Next 10 |
Biotricity, Inc. (BTCY) Q3 2023 Earnings Conference Call February 14, 2023, 04:30 PM ET Company Participants Debra Chen - Investor Relations Waqaas Al-Siddiq - Founder & Chief Executive Officer John Ayanoglou - Chief Financial Officer Conference Call Particip...
Biotricity press release ( NASDAQ: BTCY ): Q3 GAAP EPS of -$0.09 in-line. Revenue of $2.46M (+27.5% Y/Y) beats by $0.06M . For further details see: Biotricity GAAP EPS of -$0.09 in-line, revenue of $2.46M beats by $0.06M
Revenue Up 27.4% YOY Enviable 98% Customer Retention Rate Drives Subscription Recurring Rev Growth Two Major Distribution Agreements Implemented Net Loss Narrowed by One Third as Company Targets Positive Cash Flow Investor Teleconference Scheduled Today for 4:30 ET REDWOO...
REDWOOD CITY, CA / ACCESSWIRE / February 9, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Tuesday, February 14 th , 2023 at 4:30 p.m. ET to discuss its fin...
The Wearable Medical Devices Market size is expected to be worth around USD 196.7 billion by 2030 valued at USD 21.7 billion in 2021 and growing at a CAGR of 28.3% during the forecast period from 2022 to 2030. This comprehensive analysis of the fastest-growing Wearable Medical...
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announce that it is one of only eight companies selected to present at the 2nd Annual Innovation Showca...
REDWOOD CITY, CA / ACCESSWIRE / January 26, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it has signed its second distribution agreement with a top five US medical device distributor for the...
REDWOOD CITY, CA / ACCESSWIRE / January 23, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference,...
REDWOOD CITY, CA / ACCESSWIRE / January 17, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has signed an agreement with a leading group purchasing organization ("GPO") for national distri...
Designed to support revenue growth by expanding biotres form factors for the early detection of cardiac arrhythmias in the $5 billion-dollar holter monitor market REDWOOD CITY, CA / ACCESSWIRE / December 12, 2022 / Biotricity, Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a medical d...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...